idiopathic neonatal atrial flutter
ORPHA: 454521 Treatment Available
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Digoxin | Oral tablets 0.125mg, 0.25mg; IV injection 0.25mg/mL | FDA Approved | 10 | 7d |
Clinical Presentation
Signs and symptoms associated with idiopathic neonatal atrial flutter, sourced from HPO and Orphanet clinical annotations.
Abnormal EKGSupraventricular tachycardiaAbnormal atrioventricular conductionArrhythmiaTachypneaParoxysmal supraventricular tachycardiaAbnormal left ventricular functionReduced left ventricular ejection fractionAbnormal QRS complexLarge for gestational ageHydrops fetalisRespiratory distressFeeding difficulties in infancyFetal distress
Classification & Codes
Orphanet Code
ORPHA:45452idiopathic neonatal atrial flutter
| Orphanet | ORPHA:45452 |
| Treatments | 1 drug(s) |
| Symptoms on record | 14 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO